119 related articles for article (PubMed ID: 24788627)
1. Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma.
Yi B; Hu Y; Qin G; Gu W; Zhu X; He S; Zhou J; Li D
Int J Mol Med; 2014 Jul; 34(1):205-12. PubMed ID: 24788627
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of RhoGDI2 correlates with the progression and prognosis of pancreatic carcinoma.
Yi B; Zhang Y; Zhu D; Zhang L; Song S; He S; Zhang B; Li D; Zhou J
Oncol Rep; 2015 Mar; 33(3):1201-6. PubMed ID: 25573518
[TBL] [Abstract][Full Text] [Related]
3. Rho GDP dissociation inhibitor beta promotes cell proliferation and invasion by modulating the AKT pathway in hepatocellular carcinoma.
Fang Y; Yi J; Lizhi L; Qiucheng C
DNA Cell Biol; 2014 Nov; 33(11):781-6. PubMed ID: 25180836
[TBL] [Abstract][Full Text] [Related]
4. RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway.
Niu H; Wu B; Peng Y; Jiang H; Zhang Y; Wang J; Zhang Y; He P
Tumour Biol; 2015 Jan; 36(1):409-19. PubMed ID: 25266803
[TBL] [Abstract][Full Text] [Related]
5. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
6. RhoGDI2 is expressed in human trophoblasts and involved in their migration by inhibiting the activation of RAC1.
Liu S; Cui H; Li Q; Zhang L; Na Q; Liu C
Biol Reprod; 2014 Apr; 90(4):88. PubMed ID: 24554735
[TBL] [Abstract][Full Text] [Related]
7. RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer.
Cho HJ; Baek KE; Park SM; Kim IK; Choi YL; Cho HJ; Nam IK; Hwang EM; Park JY; Han JY; Kang SS; Kim DC; Lee WS; Lee MN; Oh GT; Kim JW; Lee CW; Yoo J
Clin Cancer Res; 2009 Apr; 15(8):2612-9. PubMed ID: 19351766
[TBL] [Abstract][Full Text] [Related]
8. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ.
Zhang X; Shi G; Gao F; Liu P; Wang H; Tan X
Oncol Rep; 2019 Apr; 41(4):2117-2125. PubMed ID: 30720116
[TBL] [Abstract][Full Text] [Related]
9. Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line via a RhoGDI2/Rac1/NF-κB Signaling Pathway.
Zhang M; Ding G; Zhou L; Shen T; Xu X; Zhao T; Jia S; Cao L
J Interferon Cytokine Res; 2018 Sep; 38(9):413-422. PubMed ID: 30192158
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
11. Effects and mechanism of integrin-β1 gene expression inhibited by shRNA in invasion of pancreatic carcinoma PANC-1 cells.
Yu F; Li H; Bu X; Zhang Y
Hepatogastroenterology; 2012; 59(114):561-4. PubMed ID: 22353524
[TBL] [Abstract][Full Text] [Related]
12. TAT-RhoGDI2, a novel tumor metastasis suppressor fusion protein: expression, purification and functional evaluation.
Xu R; Dong Y; Wang L; Tao X; Sun A; Wei D
Appl Microbiol Biotechnol; 2014 Dec; 98(23):9633-41. PubMed ID: 25142698
[TBL] [Abstract][Full Text] [Related]
13. RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression.
Yi B; Hu Y; Zhu D; Yao J; Zhou J; Zhang Y; He Z; Zhang L; Zhang Z; Yang J; Tang Y; Huang Y; Li D; Liu Q
Genes Genomics; 2022 May; 44(5):561-569. PubMed ID: 35147897
[TBL] [Abstract][Full Text] [Related]
14. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.
Kim IK; Park SM; Cho HJ; Baek KE; Nam IK; Park SH; Ryu KJ; Ryu J; Choi J; Hong SC; Kim JW; Lee CW; Kang SS; Yoo J
Oncotarget; 2013 Nov; 4(11):2045-56. PubMed ID: 24185104
[TBL] [Abstract][Full Text] [Related]
16. Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis.
Niu H; Li H; Xu C; He P
Oncol Rep; 2010 Aug; 24(2):465-71. PubMed ID: 20596634
[TBL] [Abstract][Full Text] [Related]
17. Adenosine Inhibits Ovarian Cancer Growth Through Regulating RhoGDI2 Protein Expression.
Xia B; Wang J
Drug Des Devel Ther; 2019; 13():3837-3844. PubMed ID: 32109988
[TBL] [Abstract][Full Text] [Related]
18. Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1.
Li J; Hu GH; Kong FJ; Wu KM; He B; Song K; Sun WJ
Neoplasma; 2014; 61(2):144-52. PubMed ID: 24299310
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
Tan X; Egami H; Nozawa F; Abe M; Baba H
Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791
[TBL] [Abstract][Full Text] [Related]
20. Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases.
Katchman BA; Antwi K; Hostetter G; Demeure MJ; Watanabe A; Decker GA; Miller LJ; Von Hoff DD; Lake DF
Mol Cancer Res; 2011 Dec; 9(12):1621-31. PubMed ID: 21989104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
